{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/20/3276890/0/en/Palvella-Therapeutics-to-Present-QTORIN-Rapamycin-Results-from-Phase-3-SELVA-and-Phase-2-TOIVA-Studies-at-the-International-Society-for-the-Study-of-Vascular-Anomalies-World-Congre.html", "message": "News view counter 671053 successfully enlarged"}